Behçet's syndrome patients exhibit specific microbiome signature C Consolandi, S Turroni, G Emmi, M Severgnini, J Fiori, C Peano, E Biagi, ... Autoimmunity reviews 14 (4), 269-276, 2015 | 256 | 2015 |
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status PA Lyons, JE Peters, F Alberici, J Liley, RMR Coulson, W Astle, C Baldini, ... Nature communications 10 (1), 5120, 2019 | 218 | 2019 |
Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies P Maggi, M Absinta, M Grammatico, L Vuolo, G Emmi, G Carlucci, ... Annals of neurology 83 (2), 283-294, 2018 | 210 | 2018 |
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases G Cavalli, S Colafrancesco, G Emmi, M Imazio, G Lopalco, MC Maggio, ... Autoimmunity reviews 20 (3), 102763, 2021 | 209 | 2021 |
Sjögren’s syndrome: a systemic autoimmune disease S Negrini, G Emmi, M Greco, M Borro, F Sardanelli, G Murdaca, F Indiveri, ... Clinical and experimental medicine 22 (1), 9-25, 2022 | 199 | 2022 |
SARS-CoV-2 infection among patients with systemic autoimmune diseases G Emmi, A Bettiol, I Mattioli, E Silvestri, G Di Scala, ML Urban, A Vaglio, ... Autoimmunity reviews 19 (7), 102575, 2020 | 183 | 2020 |
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course L Cavagna, E Trallero-Araguás, F Meloni, I Cavazzana, J Rojas-Serrano, ... Journal of clinical medicine 8 (11), 2013, 2019 | 173 | 2019 |
Thrombosis in vasculitis: from pathogenesis to treatment G Emmi, E Silvestri, D Squatrito, A Amedei, E Niccolai, MM D’Elios, ... Thrombosis journal 13, 1-10, 2015 | 170 | 2015 |
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome FX Danlos, GM Rossi, D Blockmans, G Emmi, A Kronbichler, S Durupt, ... Autoimmunity Reviews 16 (10), 1036-1043, 2017 | 150 | 2017 |
Thrombosis in inflammatory bowel diseases: what’s the link? M Giannotta, G Tapete, G Emmi, E Silvestri, M Milla Thrombosis Journal 13, 1-9, 2015 | 148 | 2015 |
Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Behçet disease M Becatti, G Emmi, E Silvestri, G Bruschi, L Ciucciarelli, D Squatrito, ... Circulation 133 (3), 302-311, 2016 | 147 | 2016 |
Vascular Behçet’s syndrome: an update G Emmi, A Bettiol, E Silvestri, G Di Scala, M Becatti, C Fiorillo, D Prisco Internal and emergency medicine 14, 645-652, 2019 | 141 | 2019 |
Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma A Amedei, F Munari, CD Bella, E Niccolai, M Benagiano, L Bencini, ... Internal and emergency medicine 9, 303-309, 2014 | 140 | 2014 |
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study C Fabiani, A Vitale, G Emmi, G Lopalco, L Vannozzi, S Guerriero, ... Clinical rheumatology 36, 191-197, 2017 | 137 | 2017 |
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: the IRAP (International Registry of Anakinra for Pericarditis) study M Imazio, A Andreis, GM De Ferrari, PC Cremer, V Mardigyan, ... European journal of preventive cardiology 27 (9), 956-964, 2020 | 123 | 2020 |
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study G Emmi, R Talarico, G Lopalco, R Cimaz, F Cantini, O Viapiana, I Olivieri, ... Clinical Rheumatology 35, 1281-1286, 2016 | 119 | 2016 |
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric … L Iaccarino, L Andreoli, EB Bocci, A Bortoluzzi, F Ceccarelli, F Conti, ... Journal of autoimmunity 86, 1-8, 2018 | 116 | 2018 |
Behçet: the syndrome A Bettiol, D Prisco, G Emmi Rheumatology 59 (Supplement_3), iii101-iii107, 2020 | 111 | 2020 |
Neutrophil extracellular traps profiles in patients with incident systemic lupus erythematosus and lupus nephritis M Bruschi, A Bonanni, A Petretto, A Vaglio, F Pratesi, L Santucci, ... The Journal of rheumatology 47 (3), 377-386, 2020 | 111 | 2020 |
Efficacy and safety of adalimumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study C Fabiani, A Vitale, G Emmi, L Vannozzi, G Lopalco, S Guerriero, ... Clinical rheumatology 36, 183-189, 2017 | 105 | 2017 |